ATE250032T1 - Mikropartikularform eines tetrahydropyridinderivates - Google Patents

Mikropartikularform eines tetrahydropyridinderivates

Info

Publication number
ATE250032T1
ATE250032T1 AT97952987T AT97952987T ATE250032T1 AT E250032 T1 ATE250032 T1 AT E250032T1 AT 97952987 T AT97952987 T AT 97952987T AT 97952987 T AT97952987 T AT 97952987T AT E250032 T1 ATE250032 T1 AT E250032T1
Authority
AT
Austria
Prior art keywords
tetrahydropyridine derivative
microparticular form
microparticular
tetrahydropyridine
derivative
Prior art date
Application number
AT97952987T
Other languages
English (en)
Inventor
Antoine Caron
Jean-Pierre Chambon
Olivier Monnier
Original Assignee
Sanofi Synthelabo
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Synthelabo filed Critical Sanofi Synthelabo
Application granted granted Critical
Publication of ATE250032T1 publication Critical patent/ATE250032T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/68—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D211/70—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/10—Laxatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/06—Free radical scavengers or antioxidants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
AT97952987T 1996-12-23 1997-12-23 Mikropartikularform eines tetrahydropyridinderivates ATE250032T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9615905A FR2757510B1 (fr) 1996-12-23 1996-12-23 Forme microparticulaire d'un derive de tetrahydropyridine
PCT/FR1997/002394 WO1998028272A1 (fr) 1996-12-23 1997-12-23 Forme microparticulaire d'un derive de tetrahydropyridine

Publications (1)

Publication Number Publication Date
ATE250032T1 true ATE250032T1 (de) 2003-10-15

Family

ID=9499044

Family Applications (1)

Application Number Title Priority Date Filing Date
AT97952987T ATE250032T1 (de) 1996-12-23 1997-12-23 Mikropartikularform eines tetrahydropyridinderivates

Country Status (38)

Country Link
US (4) US20020028247A1 (de)
EP (1) EP0950051B1 (de)
JP (2) JP4422214B2 (de)
KR (1) KR100455797B1 (de)
CN (1) CN1088698C (de)
AR (1) AR009673A1 (de)
AT (1) ATE250032T1 (de)
AU (1) AU730302B2 (de)
BR (1) BR9714177A (de)
CA (1) CA2275593C (de)
CO (1) CO4920213A1 (de)
CZ (1) CZ294272B6 (de)
DE (1) DE69724999T2 (de)
DK (1) DK0950051T3 (de)
DZ (1) DZ2386A1 (de)
EE (1) EE04112B1 (de)
EG (1) EG24749A (de)
ES (1) ES2207758T3 (de)
FR (1) FR2757510B1 (de)
HK (1) HK1024000A1 (de)
HU (1) HU224348B1 (de)
IL (1) IL129937A (de)
IN (1) IN186977B (de)
IS (1) IS2064B (de)
MY (1) MY126298A (de)
NO (1) NO311569B1 (de)
NZ (1) NZ336129A (de)
PL (1) PL190098B1 (de)
PT (1) PT950051E (de)
RU (1) RU2193031C2 (de)
SI (1) SI0950051T1 (de)
SK (1) SK283917B6 (de)
TR (1) TR199901362T2 (de)
TW (1) TW534820B (de)
UA (1) UA66776C2 (de)
WO (1) WO1998028272A1 (de)
YU (1) YU49427B (de)
ZA (1) ZA9711579B (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4570357B2 (ja) * 2001-07-06 2010-10-27 ライフサイクル ファーマ エー／エス 制御された凝集
BE1015641A4 (fr) * 2003-05-26 2005-07-05 Mariani Jean Paul Micronisation 70.
RU2472490C1 (ru) * 2011-08-05 2013-01-20 Открытое акционерное общество "Биосинтез" Средство для лечения кожных гнойных инфекций, составы и способы получения

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US562883A (en) * 1896-06-30 Thill-coupling
FR2531707A1 (fr) * 1982-08-16 1984-02-17 Midy Spa Trifluoromethylphenyltetrahydropyridines substituees a activite anorexigene, un procede de preparation et compositions pharmaceutiques
US4826689A (en) * 1984-05-21 1989-05-02 University Of Rochester Method for making uniformly sized particles from water-insoluble organic compounds
FR2627696B1 (fr) * 1988-02-26 1991-09-13 Fournier Innovation Synergie Nouvelle forme galenique du fenofibrate
FR2639226B1 (fr) * 1988-11-18 1993-11-05 Sanofi Utilisation de trifluoromethylphenyltetrahydropyridines pour la preparation de medicaments destines a combattre les troubles anxio-depressifs
FR2662355B1 (fr) * 1990-05-22 1994-11-10 Sanofi Sa Utilisation de la 1-[2-(2-naphtyl)ethyl]-4-(3-trifluoromethylphenyl)-1,2,3,6-tetrahydropyridine pour la preparation de medicaments destines au traitement de troubles cerebraux et neuronaux.
CA2126685C (en) * 1992-10-26 2002-07-23 Bruno Gander Process for the production of microcapsules
US5662883A (en) * 1995-01-10 1997-09-02 Nanosystems L.L.C. Microprecipitation of micro-nanoparticulate pharmaceutical agents
US5560932A (en) * 1995-01-10 1996-10-01 Nano Systems L.L.C. Microprecipitation of nanoparticulate pharmaceutical agents
US6489334B2 (en) * 1996-12-23 2002-12-03 Sanofi-Synthelabo Method for the crystallization of a tetrahydropyridin derivative and resulting crystalline forms
FR2763847B1 (fr) * 1997-05-28 2003-06-06 Sanofi Sa Utilisation de tetrahydropyridines 4-substituees pour fabriquer des medicaments agissant sur le tgf-beta-1
US20020147216A1 (en) * 2000-01-31 2002-10-10 Yuhong Zhou Mucin synthesis inhibitors

Also Published As

Publication number Publication date
SI0950051T1 (en) 2004-02-29
JP2001507013A (ja) 2001-05-29
CN1088698C (zh) 2002-08-07
DE69724999T2 (de) 2004-07-22
IL129937A0 (en) 2000-02-29
CO4920213A1 (es) 2000-05-29
HU224348B1 (hu) 2005-08-29
HK1024000A1 (en) 2000-09-29
YU28899A (sh) 2000-03-21
CZ229199A3 (cs) 1999-09-15
AR009673A1 (es) 2000-04-26
DK0950051T3 (da) 2004-01-26
NO311569B1 (no) 2001-12-10
RU2193031C2 (ru) 2002-11-20
JP2009280581A (ja) 2009-12-03
TR199901362T2 (xx) 1999-09-21
US20020192292A1 (en) 2002-12-19
CN1241179A (zh) 2000-01-12
EE04112B1 (et) 2003-08-15
ES2207758T3 (es) 2004-06-01
NO993077D0 (no) 1999-06-22
FR2757510B1 (fr) 2000-01-07
EE9900263A (et) 2000-02-15
HUP0001181A2 (hu) 2000-11-28
DZ2386A1 (fr) 2002-12-28
EP0950051B1 (de) 2003-09-17
KR20000069503A (ko) 2000-11-25
CA2275593C (en) 2005-12-20
IN186977B (de) 2001-12-22
BR9714177A (pt) 2000-02-29
CZ294272B6 (cs) 2004-11-10
US20020028247A1 (en) 2002-03-07
JP4422214B2 (ja) 2010-02-24
PL190098B1 (pl) 2005-10-31
TW534820B (en) 2003-06-01
DE69724999D1 (de) 2003-10-23
YU49427B (sh) 2006-01-16
KR100455797B1 (ko) 2004-11-06
SK82999A3 (en) 1999-12-10
PL334276A1 (en) 2000-02-14
ZA9711579B (en) 1998-06-25
PT950051E (pt) 2004-02-27
UA66776C2 (uk) 2004-06-15
EP0950051A1 (de) 1999-10-20
US20100021541A1 (en) 2010-01-28
IL129937A (en) 2002-09-12
AU730302B2 (en) 2001-03-01
WO1998028272A1 (fr) 1998-07-02
US20080255365A1 (en) 2008-10-16
SK283917B6 (sk) 2004-05-04
CA2275593A1 (en) 1998-07-02
FR2757510A1 (fr) 1998-06-26
IS5077A (is) 1999-06-10
AU5668598A (en) 1998-07-17
IS2064B (is) 2005-11-15
NO993077L (no) 1999-06-22
HUP0001181A3 (en) 2003-03-28
MY126298A (en) 2006-09-29
NZ336129A (en) 2000-11-24
EG24749A (en) 2010-07-20

Similar Documents

Publication Publication Date Title
PT988310E (pt) Derivados 4"-substituido-9-desoxo-9a-aza-9a-homoeritromicina a
BR9704031A (pt) Derivados de 4 hidróxi piperidina
ATE278695T1 (de) Piperidinderivate
DE69618987D1 (de) Injizierbare quinolonformulierungen
DK0991658T3 (da) Dolastatin 15-derivater
DK0842170T3 (da) Diphenylmethylen-piperidin-derivater
ZA952431B (en) New piperidine derivatives
DE69216260T2 (de) Piperidinderivate
ATE250032T1 (de) Mikropartikularform eines tetrahydropyridinderivates
DK0846683T3 (da) 4-hydroxypiperidinderivater
ID18012A (id) Proses higiene perorangan sinergis
DE69521745T2 (de) Diazacycloalkanalkylsulfonamid-derivat
NO992302L (no) Piperidin-derivater
DE69725613D1 (de) Neue therapeutische verwendung eines thienylcyclohexylaminderivates
NO970144L (no) Trifluormetylkinolinkarboksylsyre-derivat
DE9419459U1 (de) Schornsteinkopf
DE9416932U1 (de) Mauerkopfabdeckung
DE29511898U1 (de) Stützenkopf
NO20001778L (no) Substituerte piperidinderivater
DE9401345U1 (de) Wind-Sturm Ableitungskonstruktion
KR970006301A (ko) -피페리딘 또는 테트라하이드로피리딘 아자비사이클로카복스아미드
KR950026489U (ko) 장식용 상
DK0755927T3 (da) Dimethylfurancarboxyanilidderivat
DE29517611U1 (de) Schornsteinkopf
KR970002959U (ko) 헤드 클리너

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 0950051

Country of ref document: EP